Onco Wiki / Indication

Breast cancer (invasive) · None

Deterministic view of the source YAML entity. Clinical authority remains with the cited source IDs and reviewer sign-off state.

Knowledge-base record for audit. Provisional clinical content: this is not a prescription. An oncologist must verify original sources, applicability and review status. Full rules and constraints are in the YAML.

Source YAML: complete record

Trackstandard
Linked regimenNone
IDIND-REPRODUCTIVE-OCP-LONG-TERM-COUNSELING
TypeIndication
Statusreviewed 2026-05-18 | pending_clinical_signoff
DiseasesDIS-BREAST
SourcesSRC-NCCN-BREAST-2025 SRC-NCCN-CERVICAL-2025 SRC-NCCN-OVARIAN-2025 SRC-NCCN-UTERINE-2025

Notes

STUB — v0.3 reproductive prevention pilot (OCP long-term). Risk-benefit balanced counseling — NOT unidirectional risk warning. Known controversy (not yet captured as structured KnownControversy entity): BRCA1 carriers — OCP modestly increases breast cancer risk but is among the most effective non-surgical ovarian cancer prevention options; some guidelines recommend, others prefer prophylactic salpingectomy/oophorectomy. Two-Clinical-Co-Lead signoff queued.

Used By

No reverse references found in the YAML corpus.